Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

被引：0

作者：

T Iwasa

I Okamoto

K Takezawa

K Yamanaka

T Nakahara

A Kita

H Koutoku

M Sasamata

E Hatashita

Y Yamada

K Kuwata

M Fukuoka

K Nakagawa

机构：

[1] Kinki University School of Medicine,Department of Medical Oncology

[2] 377-2 Ohno-higashi,Department of Medical Oncology

[3] Osaka-Sayama,undefined

[4] Osaka 589-8511,undefined

[5] Japan,undefined

[6] Institute of Drug Discovery Research,undefined

[7] Astellas Pharma Inc.,undefined

[8] 21 Miyukigaoka,undefined

[9] Tsukuba-shi,undefined

[10] Ibaraki 305-8585,undefined

[11] Japan,undefined

[12] Kinki University School of Medicine,undefined

[13] Sakai Hospital,undefined

[14] 2-7-1 Harayamadai,undefined

[15] Minami-ku Sakai,undefined

[16] Osaka 590-0132,undefined

[17] Japan,undefined

来源：

British Journal of Cancer | 2010年 / 103卷

关键词：

survivin; YM155; apoptosis; DNA repair; non-small cell lung cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：36 / 42

页数：6